Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration
Rozanna Meijboom(MRC Centre for Regenerative Medicine), Adam Waldman(Royal Society of Edinburgh), María Valdés Hernández(Scottish and Southern Energy (United Kingdom)), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Yair Mina(National Institutes of Health), Steven Jacobson(National Institute of Neurological Disorders and Stroke), Govind Nair(National Institutes of Health), Siddharthan Chandran(Edinburgh Royal Infirmary), Agniete Kampaite(University of Edinburgh), Nicole White(University of Edinburgh), Daisy Mollison(University of Edinburgh), Niall MacDougall(MRC Centre for Regenerative Medicine), Peter Connick(University of Cambridge), Elizabeth N. York(University of Edinburgh), Peter Foley(MRC Centre for Regenerative Medicine), Patrick K. A. Kearns(University of Edinburgh), Katy Murray(MRC Centre for Regenerative Medicine), Daniel S. Reich(National Institutes of Health)
Cited by 7
Related Papers
Neuroimaging standards for research into small vessel disease—advances since 2013
|The Lancet Neurology|2023|962
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646